MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-KL-13-0009620
Molecular Cyclotrons Private Limited - pharma in Thrissur, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹10.3 Cr
▲ 25% YoY
Net profit · FY 2024
₹1.76 Cr
Net margin 17%
EBITDA · FY 2024
₹4.23 Cr
EBITDA margin 41.1%
Authorised capital
₹3.5 Cr
Registered with MCA
Paid-up capital
₹3.35 Cr
Issued & subscribed
Satisfied charges
₹11.26 Cr
No open charges
Company age
15 yrs
Est. 2011
Directors on board
5
As per MCA filings
About Molecular Cyclotrons Private Limited
Data last updated:
Molecular Cyclotrons Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U52310KL2011PTC028744. Its GSTIN is 32AAICM6609A1ZW (Kerala).
The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹3.35 Cr. It was formerly known as Ceevees Medical Radioisotopes Private Limited. It is led by directors including Chirayath Paulson Varkey (Managing Director) and Kizhakkebhagathu Ajith Joy (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at VIII/843 Ceeveesadan Ancherichira P O, Thrissur, Kerala, India – 680006.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.3 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹1.76 Cr (net margin 17%) and EBITDA of ₹4.23 Cr (EBITDA margin 41.1%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 24% over five years.
As per MCA filings, the company has satisfied charges of ₹11.26 Cr on record.
Molecular Cyclotrons Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-13-0009620). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website molecularcyclotrons.com.
Company Details of Molecular Cyclotrons Private Limited
CIN U52310KL2011PTC028744
Registration Number 028744
Incorporation Date 29 June 2011
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KL-13-0009620
Key People
Chirayath Paulson Varkey Managing Director Kizhakkebhagathu Ajith Joy Managing Director Mibu Jose Director Recognitions & Rankings of Molecular Cyclotrons
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressVIII/843 Ceeveesadan Ancherichira P O, Thrissur, Kerala, India – 680006
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Molecular Cyclotrons Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Molecular Cyclotrons Private Limited
The main business activity of Molecular Cyclotrons is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Molecular Cyclotrons Private Limited FY 2024 filings available
Molecular Cyclotrons Private Limited reported revenue of ₹10.3 Cr (up 25% YoY) for FY 2024.
Revenue · FY 2024
₹10.3 Cr ▲ 25%
Net profit · FY 2024
₹1.76 Cr margin 17%
EBITDA · FY 2024
₹4.23 Cr margin 41.1%
Compounded Annual Growth Rate (CAGR) of Molecular Cyclotrons Private Limited
Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 23%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 25%
5 years · compounded
▲ 26%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 25% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Molecular Cyclotrons Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.23 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.76 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Molecular Cyclotrons Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 17% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Molecular Cyclotrons are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Molecular Cyclotrons Private Limited
Molecular Cyclotrons has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mibu Jose | Director | 01 Sep 2012 | 14 Years 1 Months | Current |
| Chirayath Paulson Varkey | Managing Director | 29 Jun 2011 | 15 Years 3 Months | Current |
| Kizhakkebhagathu Ajith Joy Also directs: Vellarimala Resorts LLP, Kizhakkebhagam Eco Tourism LLP, Kizhakkebhagam Agro Fisheries LLP and 5 more | Managing Director | 29 Jun 2011 | 15 Years 3 Months | Current |
| Methale Purayil Hassan Kunhi | Director | 01 Sep 2012 | 14 Years 1 Months | Current |
| Mathew Francis Kattukkaran | Director | 01 Sep 2012 | 14 Years 1 Months | Current |
Peer Comparison of Molecular Cyclotrons Private Limited
Molecular Cyclotrons Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yagmag Labs Pvt.Ltd. | ₹10.37 Cr (FY 2019) | •••• | •••• | 227.0% | •••• | Hyderabad, Telangana, India |
| Oasis Pharma and Phytomolecules Private Limited | ₹10.36 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Chandigarh, India |
| SVS Medicare Private Limited | ₹10.34 Cr (FY 2025) | •••• | •••• | -77.0% | •••• | Solapur, Maharashtra, India |
| Essenzaa Nutrition Private Limited | ₹10.33 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Mumbai, Maharashtra, India |
| Banson Pharmaceuticals Private Limited | ₹10.3 Cr (FY 2024) | •••• | •••• | 92.0% | •••• | Punjab, India |
| Molecular Cyclotrons Private Limited this company | ₹10.3 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Thrissur, Kerala, India |
| Medwin Pharmaceuticals Private Limited | ₹10.29 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Aligarh, Uttar Pradesh, India |
| Elinor Healthcare Private Limited | ₹10.28 Cr (FY 2024) | •••• | •••• | 831.0% | •••• | Hyderabad, Telangana, India |
| Voizmed Pharma Private Limited | ₹10.24 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Panchkula, Haryana, India |
| Bestel Laboratories Private Limited | ₹10.23 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Anand, Gujarat, India |
| Kenny Pharma Private Limited | ₹10.23 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Ankleshwar, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Molecular Cyclotrons by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Molecular Cyclotrons Private Limited
Molecular Cyclotrons Private Limited is audited by UNNIKRISHNAN & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| UNNIKRISHNAN & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Molecular Cyclotrons Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Molecular Cyclotrons Private Limited
Open charges
None
Satisfied charges
₹11.26 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2021 | The Catholic Syrian Bank Ltd | ₹44 Lakh | Satisfied |
| 28 Sep 2021 | The Catholic Syrian Bank Ltd | ₹1 Cr | Satisfied |
| 30 Sep 2014 | Others | ₹2.19 Cr | Satisfied |
| 01 Jul 2014 | Others | ₹7.63 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Molecular Cyclotrons Private Limited
Employment history and EPFO contributions of people linked to Molecular Cyclotrons.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Molecular Cyclotrons Private Limited
Molecular Cyclotrons Private Limited has 6 board changes on record since 2011: 5 appointments and 1 cessation. The latest: Kizhakkebhagathu Ajith Joy ceased to be Director on 01 Jan 2013.
AGM
Molecular Cyclotrons Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 28 Sep 2021 via Charge ID 100482749 with The Catholic Syrian Bank Ltd was fully satisfied on 22 May 2024.
Filing
Molecular Cyclotrons Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
Charges
A charge registered on 01 Jul 2014 via Charge ID 10539647 with Others was fully satisfied on 09 Feb 2023.
Charges
A charge registered on 28 Sep 2021 via Charge ID 100493415 with The Catholic Syrian Bank Ltd was fully satisfied on 26 May 2022.
Charges
A charge with The Catholic Syrian Bank Ltd amounted to Rs. 0.44 Cr with Charge ID 100493415 was registered on 28 Sep 2021.
Charges
A charge with The Catholic Syrian Bank Ltd amounted to Rs. 1.00 Cr with Charge ID 100482749 was registered on 28 Sep 2021.
Charges
A charge registered on 30 Sep 2014 via Charge ID 10539649 with Others was fully satisfied on 18 Jun 2021.
Charges
A charge with Others of Rs. 2.19 Cr registered on 30 Sep 2014 with Charge ID 10539649 was modified on 14 Jun 2018.
Charges
A charge with Others of Rs. 7.63 Cr registered on 01 Jul 2014 with Charge ID 10539647 was modified on 20 Mar 2018.
Charges
A charge with Others amounted to Rs. 2.19 Cr with Charge ID 10539649 was registered on 30 Sep 2014.
Charges
A charge with Others amounted to Rs. 7.63 Cr with Charge ID 10539647 was registered on 01 Jul 2014.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Molecular Cyclotrons Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Molecular Cyclotrons Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Molecular Cyclotrons Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Molecular Cyclotrons Private Limited
Molecular Cyclotrons has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAICM6609A1ZW | Kerala | Active | 28 Sep 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Molecular Cyclotrons Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Cyclotrons Private Limited
Molecular Cyclotrons is an active private limited company based in Thrissur, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 June 2011 (15+ years old) and is registered under CIN U52310KL2011PTC028744.
Molecular Cyclotrons reported revenue of ₹10.3 Cr for FY 2024 (up 25% YoY).
Molecular Cyclotrons has 5 current directors:
- Chirayath Paulson Varkey - Managing Director
- Kizhakkebhagathu Ajith Joy - Managing Director
- Mibu Jose - Director
- Methale Purayil Hassan Kunhi - Director
- Mathew Francis Kattukkaran - Director
Molecular Cyclotrons reported a net profit of ₹1.76 Cr (net margin 17%) and EBITDA of ₹4.23 Cr (EBITDA margin 41.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Molecular Cyclotrons is 23% over three years and 24% over five years. In the latest year (FY 2024) revenue rose 25%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Molecular Cyclotrons is 32AAICM6609A1ZW, registered in Kerala.
The CIN (Corporate Identification Number) of Molecular Cyclotrons is U52310KL2011PTC028744. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Molecular Cyclotrons was incorporated on 29 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Molecular Cyclotrons by revenue are Yagmag Labs Pvt.Ltd, Oasis Pharma and Phytomolecules Private Limited, SVS Medicare Private Limited, Essenzaa Nutrition Private Limited, Banson Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Kizhakkebhagathu Ajith Joy ceased to be Director on 01 Jan 2013. Mathew Francis Kattukkaran was appointed as Director on 01 Sep 2012. Methale Purayil Hassan Kunhi was appointed as Director on 01 Sep 2012. Molecular Cyclotrons has 6 board changes on record in total.
Yes, Molecular Cyclotrons is registered as a medium enterprise under Udyam registration (number: UDYAM-KL-13-0009620).